Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL7765352

C=CCc1c(C(N)=O)ccc2ccccc12.N

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WDR5 P61964 1/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
KDM4E B2RXH2 5/20 0.40
ALDH1A1 P00352 4/20 0.40
GAA P10253 3/20 0.40
HSD17B10 Q99714 2/20 0.40
GLA P06280 1/20 0.40
HPGD P15428 1/20 0.40
POLB P06746 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MAPT P10636 2/20 0.39
ATM Q13315 1/20 0.39
LDHA P00338 1/20 0.39
TAAR1 Q96RJ0 1/20 0.39
CYP1A1 P04798 1/20 0.38
CYP1B1 Q16678 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL7532651 0.87 KDM4E (0.53) KMT2AMEN1KDM4EALDH1A1GAA
SCHEMBL9575201 0.86 CDC25B (0.45) WDR5KDM4EALDH1A1GAAHSD17B10
SCHEMBL4319334 0.84 WDR5 (0.54) WDR5KDM4EALDH1A1GAAHSD17B10
SCHEMBL5028929 0.83 WDR5 (0.41) WDR5KMT2AMEN1KDM4EALDH1A1
SCHEMBL3939222 0.82 WDR5 (0.40) WDR5KMT2AMEN1KDM4EALDH1A1
SCHEMBL23515370 0.80 HSD17B10 (0.53) WDR5KMT2AMEN1KDM4EALDH1A1
SCHEMBL29625744 0.80 HSD17B10 (0.53) WDR5KMT2AMEN1KDM4EALDH1A1
SCHEMBL14058648 0.80 KDM4E (0.42) KMT2AMEN1KDM4EALDH1A1GAA
SCHEMBL4665440 0.79 WDR5 (0.38) WDR5KMT2AMEN1KDM4EALDH1A1
SCHEMBL6801208 0.79 WDR5 (0.38) WDR5KMT2AMEN1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0873329-B1 NOVEL N-AMINOALKYLFLUORENECARBOXAMIDES; A NEW CLASS OF DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORP (US) 2001-06-06 EP disclosed
EP-1081142-A2 Novel N-Aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands NEUROGEN CORPORATION (US) 2001-03-07 EP disclosed
US-6015900-A FOR TREATMENT OF PSYCHOTIC OR CENTRAL NERVOUS SYSTEM DISORDERS NEUROGEN CORPORATION (US) 2000-01-18 US disclosed
US-5932734-A HIGH AFFINITY AND SELECTIVITY IN BINDING TO THE D3 RECEPTOR SUBTYPE; PSYCHOLOGICAL DISORDERS NEUROGEN CORPORATION (US) 1999-08-03 US disclosed
EP-0873329-A1 NOVEL N-AMINOALKYLFLUORENECARBOXAMIDES; A NEW CLASS OF DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 1998-10-28 EP disclosed
US-5659033-A PSYCHOLOGICAL DISORDERS NEUROGEN CORPORATION (US) 1997-08-19 US disclosed
WO-1997010229-A1 NOVEL N-AMINOALKYLFLUORENECARBOXAMIDES; A NEW CLASS OF DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 1997-03-20 WO disclosed